Myeloperoxidase-derived oxidants have been shown to contribute to the pathogenesis of various inflammatory diseases including IBD,8 cystic fibrosis (CF),9 rheumatoid arthritis,10 cardiovascular disease,11 and chronic obstructive pulmonary disease.12 This evidence concerns the gene MPO and cystic fibrosis.